TherapeuticsMD, Inc. (TXMD)

NASDAQ: TXMD · IEX Real-Time Price · USD
3.10
0.83 (36.56%)
At close: May 20, 2022 4:00 PM
3.05
-0.05 (-1.61%)
After-hours:May 20, 2022 7:59 PM EDT
Market Cap26.87M
Revenue (ttm)86.42M
Net Income (ttm)-182.05M
Shares Out8.67M
EPS (ttm)-21.73
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume22,132,203
Open2.26
Previous Close2.27
Day's Range2.24 - 3.35
52-Week Range2.21 - 69.50
Beta2.09
AnalystsBuy
Price Target64.26 (+1,972.9%)
Earnings DateMay 16, 2022

About TXMD

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008H...

IndustryPharmaceuticals
CEORobert Finizio
Employees416
Stock ExchangeNASDAQ
Ticker SymbolTXMD
Full Company Profile

Financial Performance

In 2021, TherapeuticsMD's revenue was $86.95 million, an increase of 34.03% compared to the previous year's $64.87 million. Losses were -$172.42 million, -6.05% less than in 2020.

Financial Statements

Analyst Forecast

According to 9 analysts, the average rating for TXMD stock is "Buy." The 12-month stock price forecast is 64.26, which is an increase of 1,972.90% from the latest price.

Price Target
$64.26
(1,972.90% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market

Are these biotech penny stocks on your watchlist right now? The post Hot Biotech Penny Stocks to Watch as Stocks Enter Bear Market  appeared first on Penny Stocks to Buy, Picks, News and Information | P...

Other symbols:CMRXIMMX
17 hours ago - PennyStocks

Why TherapeuticsMD Shares Are Trading Higher Today

TherapeuticsMD Inc (NASDAQ: TXMD) shares are trading higher after FDA approved the supplemental application, including minor revisions to Annovera's in vitro release testing specification that allowed f...

1 day ago - Benzinga

TherapeuticsMD Receives U.S. Food and Drug Administration (FDA) Approval for Supplemental New Drug Application (sNDA)...

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced the FDA's approval of a supplemental N...

1 day ago - Business Wire

TherapeuticsMD (TXMD) Reports Q1 Loss, Misses Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -34.86% and 1.41%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

4 days ago - Zacks Investment Research

TherapeuticsMD Announces First Quarter 2022 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the first quarte...

4 days ago - Business Wire

TherapeuticsMD to Report First Quarter 2022 Financial Results on May 16, 2022

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its first quarter...

1 week ago - Business Wire

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at ...

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), (“TXMD” or the “Company”) an innovative, leading women's healthcare company, announced today the closing of the divestiture of vit...

Other symbols:GDRX
1 month ago - Business Wire

Best Penny Stocks To Buy? 5 Explosive Stocks Under $1 To Watch Now

Penny Stocks Under $1 To Watch This Week. The post Best Penny Stocks To Buy?

Other symbols:LEJUMKDSECOSXTC
1 month ago - PennyStocks

TherapeuticsMD (TXMD) Reports Q4 Loss, Lags Revenue Estimates

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of -50% and 37.89%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

TherapeuticsMD Announces Fourth Quarter 2021 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the fourth quart...

2 months ago - Business Wire

Why TherapeuticsMD Shares Are Soaring Today

TherapeuticsMD Inc (NASDAQ: TXMD) is trading higher Monday after the company announced it would sell its prescription services business, vitaCare, to GoodRx Holdings Inc (NASDAQ: GDRX). Under terms of t...

2 months ago - Benzinga

Trading Penny Stocks? Top Stock Market News for March 7th, 2022

Here's what you need to know about trading penny stocks on March 7th The post Trading Penny Stocks? Top Stock Market News for March 7th, 2022 appeared first on Penny Stocks to Buy, Picks, News and Infor...

Other symbols:IMPPVEON
2 months ago - PennyStocks

TherapeuticsMD Shares Soars After VitaCare Divestiture In $150M Deal

TherapeuticsMD Inc (NASDAQ: TXMD) has agreed to divest its VitaCare Prescription Services business to GoodRx Holdings Inc (NASDAQ: GDRX) for $150 million. VitaCare is a consumer-focused digital healthca...

2 months ago - Benzinga

TherapeuticsMD Enters Into a Definitive Agreement to Divest vitaCare to GoodRx

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it has entered into a definitive...

Other symbols:GDRX
2 months ago - Business Wire

TherapeuticsMD to Report Fourth Quarter 2021 Financial Results on March 10, 2022

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that it will report its fourth quarte...

2 months ago - Business Wire

3 Penny Stocks To Watch Under $1 That Are Moving Right Now

Looking for penny stocks to buy under $1? Check these three out for your watchlist The post 3 Penny Stocks To Watch Under $1 That Are Moving Right Now appeared first on Penny Stocks to Buy, Picks, News ...

Other symbols:FAMIOGEN
4 months ago - PennyStocks

FDA Approves TherapeuticsMD's Low Dose Bijuva

TherapeuticsMD Inc (NASDAQ: TXMD) is trading sharply higher after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women with vasomotor symptoms due to m...

4 months ago - Benzinga

TherapeuticsMD's Birth Control Med Receives FDA Response Letter To Revise Manufacturing Testing Limits

TherapeuticsMD Inc (NASDAQ: TXMD) said that the FDA could not approve revisions to certain manufacturing testing limits for Annovera through the supplemental marketing application previously submitted b...

5 months ago - Benzinga

U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testi...

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ:TXMD) (“TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced that the FDA determined that it could ...

5 months ago - Business Wire

TherapeuticsMD, Amneal Settle US Patent Litigation For Bijuva

TherapeuticsMD Inc (NASDAQ: TXMD) has settled the previously disclosed U.S. patent litigation for Bijuva with Amneal Pharmaceuticals Inc (NYSE: AMRX). Bijuva is a prescription medicine used to treat vas...

Other symbols:AMRX
5 months ago - Benzinga

TherapeuticsMD Settles U.S. Patent Litigation with Amneal for BIJUVA® (Estradiol and Progesterone) — Allowing for a M...

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the settlement of the previously disclosed U.S. patent litigati...

5 months ago - Business Wire

Recap: TherapeuticsMD Q3 Earnings

TherapeuticsMD (NASDAQ:TXMD) reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

6 months ago - Benzinga

TherapeuticsMD Announces Third Quarter 2021 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the third quarte...

6 months ago - Business Wire

TherapeuticsMD Announces Leadership Changes; Appointment of Industry Veteran, Hugh O'Dowd, as Chief Executive Officer

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (TXMD or the Company), an innovative, leading women's healthcare company, today announced key leadership changes, including the app...

6 months ago - Business Wire

TherapeuticsMD (TXMD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

TherapeuticsMD (TXMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research